Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3755115rdf:typepubmed:Citationlld:pubmed
pubmed-article:3755115lifeskim:mentionsumls-concept:C0040128lld:lifeskim
pubmed-article:3755115lifeskim:mentionsumls-concept:C0016055lld:lifeskim
pubmed-article:3755115lifeskim:mentionsumls-concept:C0032105lld:lifeskim
pubmed-article:3755115lifeskim:mentionsumls-concept:C0441889lld:lifeskim
pubmed-article:3755115lifeskim:mentionsumls-concept:C0392747lld:lifeskim
pubmed-article:3755115lifeskim:mentionsumls-concept:C0443172lld:lifeskim
pubmed-article:3755115pubmed:issue5lld:pubmed
pubmed-article:3755115pubmed:dateCreated1986-7-25lld:pubmed
pubmed-article:3755115pubmed:abstractTextThe plasma levels of fibronectin (Fn) have been measured in normal subjects and in patients with thyroid diseases. The mean plasma Fn levels in 62 normal adults was 32.0 +/- 6.0 mg/dl, whereas it was elevated to 62.6 +/- 16.1 mg/dl (mean +/- SD) in 25 patients with hyperthyroidism and decreased to 19.2 +/- 8.0 mg/dl in 9 patients with hypothyroidism. The 9 patients with simple goiter have normal values of 29.1 +/- 8.0 mg/dl. With the administration of anti-thyroid drugs, plasma Fn levels normalized, with a time lag, in parallel with normalization of the thyroid function. Positive correlation was obtained between Fn levels and serum levels of triiodothyronine (T3) and thyroxine (T4). The present findings indicate that measurement of plasma Fn both in the basal state and during treatment provides evidence of altered Fn metabolism in thyroid diseases and serves to follow up the effect of treatment.lld:pubmed
pubmed-article:3755115pubmed:languageenglld:pubmed
pubmed-article:3755115pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3755115pubmed:citationSubsetIMlld:pubmed
pubmed-article:3755115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3755115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3755115pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3755115pubmed:statusMEDLINElld:pubmed
pubmed-article:3755115pubmed:monthMaylld:pubmed
pubmed-article:3755115pubmed:issn0018-5043lld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:WatanabeSSlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:SaitoSSlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:NishinoHHlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:HiraiYYlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:SaitoHHlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:ShirakamiAAlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:ShigekiyoTTlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:InomotoTTlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:TakeichiTTlld:pubmed
pubmed-article:3755115pubmed:authorpubmed-author:KawauchiSSlld:pubmed
pubmed-article:3755115pubmed:issnTypePrintlld:pubmed
pubmed-article:3755115pubmed:volume18lld:pubmed
pubmed-article:3755115pubmed:ownerNLMlld:pubmed
pubmed-article:3755115pubmed:authorsCompleteYlld:pubmed
pubmed-article:3755115pubmed:pagination345-8lld:pubmed
pubmed-article:3755115pubmed:dateRevised2009-2-19lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:meshHeadingpubmed-meshheading:3755115-...lld:pubmed
pubmed-article:3755115pubmed:year1986lld:pubmed
pubmed-article:3755115pubmed:articleTitleChanges in plasma fibronectin levels in thyroid diseases.lld:pubmed
pubmed-article:3755115pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3755115pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed